Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Long Term Follow-up Hybrid Revascularization

NCT01955330 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated 6 Nov 2018

What is being tested
Robotic Hybrid coronary artery revascularization
For
Coronary Artery Disease
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 50 people. The full rules are on the registry page.
Where
Canada
When
Starts or started Sept 2013, ends Sept 2018. Registered 7 Oct 2013.
Results
None posted yet.

In the researchers' words

OBJECTIVES: The objectives of the year study are two-fold: 1. To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft and stent of patients who have already had robotically-assisted Hybrid CABG surgery using CTA and MPS-MIBI. 2. To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG surgery
ClinicalTrials.gov, NCT01955330

Sites

  • London Health Sciences Centre, University & Victoria HospitalsLondon, Ontario, Canada